Vaxcell Bio Therapeutics banner
V

Vaxcell Bio Therapeutics
KOSDAQ:323990

Watchlist Manager
Vaxcell Bio Therapeutics
KOSDAQ:323990
Watchlist
Price: 4 365 KRW 0.92%
Market Cap: ₩101.5B

Wall St Price Targets

Price Targets Summary
Vaxcell Bio Therapeutics

There are no price targets for Vaxcell Bio Therapeutics.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Vaxcell Bio Therapeutics Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Revenue Forecast
is not available for Vaxcell Bio Therapeutics

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Vaxcell Bio Therapeutics

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Vaxcell Bio Therapeutics

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Vaxcell Bio Therapeutics

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Vaxcell Bio Therapeutics
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Vaxcell Bio Therapeutics's stock price target?
Not Available

Vaxcell Bio Therapeutics does not have any price targets made by Wall Street professionals.

Back to Top